APA (7th ed.) Citation

Kuźniewska, A., Majeranowski, A., Henry, S., Kowalska, D., Stasiłojć, G., Urban, A., . . . Okrój, M. (2024). The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab. Cancers, 16(1), 49. https://doi.org/10.3390/cancers16010049

Chicago Style (17th ed.) Citation

Kuźniewska, Alicja, Alan Majeranowski, Sara Henry, Daria Kowalska, Grzegorz Stasiłojć, Aleksandra Urban, Jan M. Zaucha, and Marcin Okrój. "The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab." Cancers 16, no. 1 (2024): 49. https://doi.org/10.3390/cancers16010049.

MLA (9th ed.) Citation

Kuźniewska, Alicja, et al. "The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab." Cancers, vol. 16, no. 1, 2024, p. 49, https://doi.org/10.3390/cancers16010049.